5 mg/kg CM-101
CM-101-NASH-201
Phase 2 mab completed
Quick answer
5 mg/kg CM-101 for Nonalcoholic Steatohepatitis is a Phase 2 program (mab) at Chemomab Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Chemomab Therapeutics
- Indication
- Nonalcoholic Steatohepatitis
- Phase
- Phase 2
- Modality
- mab
- Status
- completed